President Trump shared an anecdote about a wealthy friend's experience with inflated drug prices in the U.S., prompting a ...

WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...

A MUM has shared a downside of her epic weight loss transformation after being on Mounjaro for over two months. Scottish mum Kirsty took to TikTok after she shed almost a staggering 5 stone while ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

From Elon Musk to Chelsea Handler, find out which celebrities have admitted to taking Ozempic for weight loss. “Mob Wives” alum Renee Graziano has lost 52 pounds on Mounjaro. Renee Graziano ...

Everything you need to know about fat jabs Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name ...

Trump administration has rejected Biden proposal to expand coverage Medicare currently covers Ozempic, Mounjaro solely for diabetes Wegovy, Zepbound not covered for weight loss Trump ...

Picture: Lezli+Rose/PA In what feels like the biggest health craze in years, weight loss jabs like semaglutide (Ozempic and Wegovy) or tirzepatide (Mounjaro) have exploded in popularity.

Kyle’s daughter Sophia Umansky revealed she had taken Mounjaro, a weight loss drug similar to Ozempic, in April 2025, followed by Eric Stonestreet, with very different results.

They were prescribed either semaglutide (Ozempic, Wegovy) or liraglutide (Saxenda) for weight loss. Mounjaro is the brand name for another medication, tirzepatide. Thirty-one patients did not ...